The Expression of Histone Deacetylase 1, But Not Other Class I Histone Deacetylases, Is Significantly Increased in Endometriosis
- 20 May 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Reproductive Sciences
- Vol. 20 (12), 1416-1422
- https://doi.org/10.1177/1933719113488450
Abstract
Class I histone deacetylases (HDACs-1-3) play an important role in steroid hormone–dependent gene expression and in modulating cell survival and proliferation. We analyzed their expression in a tissue microarray including 74 endometriosis samples and 30 normal endometrium controls. The mean HDAC-1 immunoreactivity score (IRS ± standard deviation) was 7.6 ± 2.5 in endometriosis and 5.3 ± 2.3 in normal endometrium (P < .001). In contrast, the IRSs of HDAC-2 and -3 were 11.7 ± 0.7 and 11.8 ± 1.1 in endometriosis and 11.6 ± 1.0 and 11.9 ± 0.4 in normal endometrium (P = .7 and P = .2), respectively. Significant correlations were found between HDAC-1 and estrogen (-alpha/-beta) and progesterone receptor expression. In conclusion, HDAC-1, but not HDAC-2/-3, was significantly increased in endometriosis and associated with steroid hormone receptor expression that may reflect interdependence. In context with the literature, specific inhibitors of HDAC-1 may have inhibitory activities similar to those of broad-spectrum HDAC inhibitors and may be clinically tolerated, which would increase their chance as an option in the treatment of endometriosis.Keywords
This publication has 29 references indexed in Scilit:
- Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed on Prior ChemotherapyJournal of Clinical Oncology, 2012
- HDAC1 and HDAC2 are Differentially Expressed in EndometriosisReproductive Sciences, 2012
- Valproic Acid and Progestin Inhibit Lesion Growth and Reduce Hyperalgesia in Experimentally Induced Endometriosis in RatsReproductive Sciences, 2012
- Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic targetHuman Reproduction, 2011
- A pilot study on the off-label use of valproic acid to treat adenomyosisFertility and Sterility, 2008
- Use of Histone Deacetylase 8 (HDAC8), a New Marker of Smooth Muscle Differentiation, in the Classification of Mesenchymal Tumors of the UterusThe American Journal of Surgical Pathology, 2006
- EndometriosisThe Lancet, 2004
- Recruitment of Distinct Chromatin-modifying Complexes by Tamoxifen-complexed Estrogen Receptor at Natural Target Gene Promoters in VivoOnline Journal of Public Health Informatics, 2004
- Histone deacetylases (HDACs): characterization of the classical HDAC familyBiochemical Journal, 2003
- Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entitiesFertility and Sterility, 1997